Právní předpis byl sestaven k datu 14.09.2025.
Zobrazené znění právního předpisu je účinné od 27.07.2013.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2014
195/2013 Sb.
195
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 3. xxxxxxxx 2013
o xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx pro xxx 2014
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx souvisejících xxxxxx, ve xxxxx xxxxxxxxxx předpisů, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx rok 2014:
1. Xxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx b (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum
Diphtheriae xxxxxxxxxx
Xxxxxx anatoxinum xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2
Virus xxxxxxxxxxxxxxx inactivatum xxxxx 3
Xxxxxxxxxx Xxx: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxxxxxxxx anatoxinum
Tetani xxxxxxxxxx
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (inaktivovaný)
typus 1 (Mahoney)
typus 2 (XXX-1)
xxxxx 3 (Saukett)
Antigenum xxxxxxxxx xxxxxxxxxx X
Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phasphas)
conjugata xxx xxxxxx anatoxinum
1b) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx (DTaP):
Diphtheriae xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) očkovací látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
| &xxxx;
Xxxxxxxxxxx anatoxinum
|
min. 30 xxxxxxxxxxxxx jednotek
|
|
Tetani xxxxxxxxxx
|
&xxxx;
xxx. 40 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxx (XX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx (69xX)
|
&xxxx;
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx X
|
&xxxx;
10 xxxxxxxxxx
|
| &xxxx;
xxx xxxxxxxxx xxxxxxxx
|
&xxxx;
20-40 mikrogramů
|
1d) xxxxxxxx xxxxx xxxxx xxxxxxx x xxxxxx - divakcína:
Anatoxinum diphtheriae xxxxxxxxxxx ... min. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx purificatum ... xxx. 40 mezinárodních xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx nákazám vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx proti xxxxxx:
Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 15 xxx věku:
Antigenum xxxxxxxxx xxxxxxxxxxx X ... 10 mikrogramů
1h) očkovací xxxxx xxxxx virové xxxxxxxxxx X od 16 let x xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx50
Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) min. 103,7 xxxxxxxx dávka xxx xxxxxxxx kulturu50
Rubeolae xxxxx xxxxxxxxxx (Xxxxxx RA 27/3) min. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
1x) xxxxxxxx xxxxx proti dětské xxxxxxxx obrně x xxxxxxxxxxxx formě:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 2 (XXX-1) ... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Saukett) ... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx metody.
1j) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx formuli:
Polysaccharidum Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9V, 10X, 11X, 12X, 14, 15B, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X ... 25 xxxxxxxxxx x každého xxxxxxxx
1x) xxxxxxxx látka xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum sérotypus 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xx méně než 2 mezinárodní xxxxxxxx
|
| &xxxx;
Xxxxxx xxxxxxxxxx
|
&xxxx;
xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx anatoxinum
|
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxx filamentosum
|
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
Xxxxx poliomyelitidis inactivatum:
|
typus 1 (xxxx Xxxxxxx)
|
&xxxx;
40 X jednotek antigenu
|
|
typus 2 (kmen XXX-1)
|
&xxxx;
8 X xxxxxxxx xxxxxxxx
|
| &xxxx;
xxxxx 3 (xxxx Xxxxxxx)
|
&xxxx;
32 X xxxxxxxx antigenu
|
NEBO
1lb) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx):
| &xxxx;
Xxxxxxxxxx toxoid
|
více xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
|
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf)
|
Pertusové xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxx
|
&xxxx;
5 mikrogramů
|
|
Fimbrie xxxx 2+3
|
&xxxx;
5 mikrogramů
|
|
Pertaktin
|
3 xxxxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)
|
&xxxx;
40 xxxxxxxxxxx D xxxxxxxx
|
| &xxxx;
Xxxxx poliomyelitis xxxx 2 (xxxxxxxxxxxx)
|
&xxxx;
8 antigenních X xxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx xxxx 3 (inaktivovaný)
|
32 xxxxxxxxxxx X jednotek
|
1m) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:
Xxxxxxxx Xxxxxxxx Xxxxxx (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 X.X.*
(xxxx Xxxxxxxxxx 1331)
*X.X. = xxxx xxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové hepatitidě X pro xxxxx xxxxxxxx xx dialyzačního xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx A (XXX) 50 xxxxxxxxxx x 1 dávce
2. Xxxxxxxxx xxxxxxx očkovacích xxxxx pro zvláštní xxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 mikrogramů
2b) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Xxxxx xxxxxx inactivatum (xxxx Xxxxxx xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx v 1 xxxxx (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx pro xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx formuli xxx xxxx:
Xxxxx hepatitis X xxxxxxxxxxx
Xxxxxxx:
xxx. XXXx. Xxxxx, XXx., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 195/2013 Sb. xxxxx xxxxxxxxx xxxx 27.7.2013.
Xx dni xxxxxxxx xxxxxx xxxxxxx xxxxx měněn či xxxxxxxxx.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.